Different Acute Tolerance Development to EEG, Psychomotor Performance and Subjective Assessment Effects after Two Intermittent Oral Doses of Alprazolam in Healthy Volunteers
Authors:
- M.J. BarbanojMBM.J. Barbanoj
- G. UrbanoGUG. Urbano
- R. AntonijoanRAR. Antonijoan
- M.R. BallesterMBM.R. Ballester
- M. ValleMVM. Valle
- 17 September 2007
- journal article
- clinical trial
- Published by S. Karger AG in Neuropsychobiology
- Vol. 55 (3-4) , 203-212
Abstract
Background/Aims: Benzodiazepines (BZDs) are the most effective of the psychotropic drugs in the treatment of anxiety disorders. Tolerance has been reported for the majority of BZDs after chronic administration. However, little attention has been paid to the possibility that tolerance might be present after the intermittent oral administration of BZDs. The objectives of the present study were to assess tolerance development after the administration of two intermittent single oral doses of alprazolam given 15 days apart in healthy volunteers, and to compare the results obtained using measures from different domains: neurophysiological, psychomotor and subjective. Methods: Twenty-four healthy volunteers received 2 mg of alprazolam orally on two experimental days, 15 days apart. Plasma concentrations and pharmacodynamics (PD) were assessed before drug intake and at different times in the following 24 h. PD was assessed through EEG (relative α and relative β-1 activities), cancellation task (total and correct number of responses) and visual analogue scales (activity and drowsiness). Results: No differences were observed in the PKs of alprazolam between occasions. A proteresis was present in both administrations for impairments of psychomotor performance and relative β-1 activity, whereas it was present only after the second administration for subjective assessments and relative α activity. The proteresis on the second occasion was higher than on the first one. Conclusions: The administration of two single oral doses of alprazolam, 2 weeks apart in healthy volunteers, yielded the same PKs on both occasions, but significant changes were observed in the PD profile. Acute tolerance was observed after the second administration. Two patterns of acute tolerance development were obtained: (1) impairments of psychomotor performance and relative β-1 activity, and (2) subjective assessments and relative α activity.Keywords
This publication has 27 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Relationships For BenzodiazepinesClinical Pharmacokinetics, 1996
- Psychopharmacology of benzodiazepines—an updateHuman Psychopharmacology: Clinical and Experimental, 1995
- Evaluation of the development of acute tolerance to the psychomotor effects of midazolam following intravenous infusions in healthy volunteersHuman Psychopharmacology: Clinical and Experimental, 1995
- Alprazolam and amitriptyline in the treatment of moderate depressionInternational Clinical Psychopharmacology, 1994
- Clinical Pharmacokinetics of AlprazolamClinical Pharmacokinetics, 1993
- Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacologyPsychiatry Research: Neuroimaging, 1992
- Pharmacokinetics and Pharmacodynamics of Alprazolam Following Single and Multiple Oral Doses of a Sustained‐Release FormulationThe Journal of Clinical Pharmacology, 1989
- International Pharmaco-EEG Group (IPEG)Neuropsychobiology, 1989
- Pharmacokinetics and Clinical Effects of Alprazolam Following Single and Multiple Oral Doses in Patients With Panic DisorderThe Journal of Clinical Pharmacology, 1986
- Benzodiazepine receptors in rat brainNature, 1977